Le Ray, Didier, Frédéric Brocard, and Réjean Dubuc. Muscarinic modulation of the trigemino-reticular pathway in lampreys. J Neurophysiol 92: 926 -938, 2004. First published March 24, 2004 10.1152/ jn.01025.2003. In lampreys, reticulospinal neurons integrate sensory inputs to adapt their control onto the spinal locomotor networks. Whether and how sensory inputs to reticulospinal neurons are modulated remains to be determined. We showed recently that cholinergic inputs onto reticulospinal neurons play a key role in the initiation of locomotion elicited by stimulation of the mesencephalic locomotor region in semi intact lampreys. Here, we examined the possible role of muscarinic acetylcholine receptors in modulating trigeminal inputs to reticulospinal neurons. A local application of muscarinic agonists onto an intracellularly recorded reticulospinal cell depressed the disynaptic responses to trigeminal stimulation. A depression was also observed when muscarinic agonists were pressure ejected over the brain stem region containing second-order neurons relaying trigeminal inputs to reticulospinal neurons. Conversely, muscarinic antagonists increased the trigeminal-evoked responses, suggesting that a muscarinic depression of sensory inputs to RS neurons is exerted tonically. The muscarinic modulation affected predominantly the N-methyl-D-aspartate (NMDA) component of the trigeminal-evoked responses. Moreover, atropine perfusion facilitated the occurrence of sustained depolarizations induced by stimulation of the trigeminal nerve, and it revealed NMDA-induced intrinsic oscillations in reticulospinal neurons. The functional significance of a muscarinic modulation of a sensory transmission to reticulospinal neurons is discussed.
I N T R O D U C T I O N
Motor control is based on interactions between centrally generated commands and incoming sensory inputs. These interactions occur at all levels of the CNS from motor networks located in the spinal cord or in the segmental ganglia (in vertebrates and invertebrates, respectively) to the brain stem and forebrain structures (for reviews, see Clarac 1991; Rossignol 1996) . Although essential, sensory inputs are nevertheless modulated to shape the information in accordance to the state and pattern of activity of the central motor networks as shown in many animal species including invertebrates (Le Ray and Cattaert 1999; Sillar and Skorupski 1986) , lower vertebrates such as lampreys (Bussières and Dubuc 1992; El Manira et al. 1997b) , and mammals (e.g., cats: Dubuc et al. 1986; Gossard et al. 1989) .
In lampreys, reticulospinal (RS) cells constitute the main descending pathway involved in the control of motor behaviors. They activate and control the spinal locomotor networks and integrate sensory inputs from different modalities (Deliagina et al. 1995; Dubuc et al. 1993a,b; Orlovsky et al. 1992; Rovainen 1982; Viana Di Prisco et al. 1995; Zompa and Dubuc 1996) , inputs from the spinal locomotor networks themselves (Dubuc and Grillner 1989; Vinay and Grillner 1993; Vinay et al. 1998) , and inputs from higher brain centers (El Manira et al. 1997a) . One brain stem region projecting to the RS cells is the mesencephalic locomotor region (MLR) recently described in lampreys Le Ray et al. 2003; Sirota et al. 2000) . This region is homologous to a region first described in cats and later in several other vertebrate species (for a review see Jordan 1998) . We have also shown that the lamprey MLR contains cholinergic cells and provides a nicotinic receptor-mediated excitation of the rhombencephalic RS neurons that contributes to swimming activity (Le Ray et al. 2003) .
The presence of cholinergic neurons in the MLR of lampreys has prompted us to investigate the possibility that muscarinic receptors also play a role in the control of locomotion. These receptors are present in the brain stem of many vertebrate species and modulate neuronal and synaptic properties (Bal et al. 1994; Klink and Alonso 1997a,b; McCormick 1992; Segal and Auerbach 1997) . Interestingly, in several vertebrate species, muscarinic effects were observed in the brain stem reticular formation (Baghdoyan and Lydic 1999; Barnes et al. 1987; Imon et al. 1996) . Recently, a muscarinic depression of the startle reflex generated by RS cells was observed in mammals (Fendt et al. 2001 ).
The present study investigated a possible muscarinic modulation of synaptic responses of lamprey RS neurons to trigeminal sensory inputs. We show that the disynaptic postsynaptic potentials (PSPs) induced by trigeminal nerve stimulation display an atropine-sensitive depression after a local application of muscarinic agonists on the recorded RS cell or on the trigeminal relay. The perfusion of muscarinic receptor antagonists produces an enhancement of the synaptic responses, suggesting a tonic muscarinic depression of trigeminal inputs to RS neurons. Atropine also reduces the threshold for eliciting depolarizing plateaus in RS cells and increases cell discharge. The muscarinic inhibition is directed mainly against the NMDA component of glutamatergic responses, and under atropine perfusion, intrinsic NMDA-induced oscillations are unmasked in RS neurons.
M E T H O D S
Experiments were performed in larval (n ϭ 41) and young adult (n ϭ 17) lampreys, Petromyzon marinus. The animals were collected from streams entering Lake Champlain. Some were purchased from ACME Lamprey. Results from larval and adult animals were com-bined because no clear differences were observed. All procedures conformed to the guidelines of the Canadian Institutes of Health Research and were approved by the University Animal Care and Use Committee. Under tricaine methanesulphonate anesthesia (MS 222, 100 mg/l, Sigma, Oakville, ON, Canada), the animals were incised along the ventral midline and eviscerated. The dissection and subsequent experiments were performed in cold Ringer with the following composition (in mM): 130 NaCl, 2.1 KCl, 2.6 CaCl 2 , 1.8 MgCl 2 , 4 HEPES, 4 dextrose, and 1 NaHCO 3 . The rostral end of the body up to the last gill was dissected, isolating the brain and spinal cord with the underlying cranium and notochord kept for support. The spinal cord was then cut at the level of the first segment (Fig. 1A) and the preparation was pinned down to the silicone elastomer (Sylgard) bottom of an experimental chamber perfused with oxygenated cold Ringer (9°C; pH 7.4). A semi-intact preparation (n ϭ 4) was also used, where the rostral end of the animal was dissected out as described in the preceding text and pinned down to the Sylgard bottom of the experimental chamber, whereas the caudal two-thirds of the body and the tail were left intact to swim freely behind in the Ringer solution. For decerebration purposes, a complete transection was made either above or below (Fig. 1A ) the mesencephalon. There was no difference in the responses to the local application of muscarinic agonists whether the mesencephalon was kept or not. During the course of the experiments, the brain stem was constantly perfused with Ringer (2 ml/min).
RS neurons in the middle (MRRN, n ϭ 62) and posterior (PRRN, n ϭ 3) rhombencephalic reticular nuclei were impaled under visual inspection with sharp glass microelectrodes (4 M K-acetate, ϳ100 M⍀; Fig. 1A) . The recorded cells were the largest reticular neurons in these two reticular nuclei of the lamprey including the Müller cells in the MRRN (see Rovainen 1982) . The signals were recorded with an Axoclamp 2A (Axon Instruments, Foster City, CA) and directed to a computer (sampling rate: 2-10 kHz) through a TL-1 DMA interface (Axon Instruments). All neurons had a resting membrane potential (mean value: Ϫ74.6 Ϯ 0.6 mV) that remained constant throughout the experiment. The effects of drug applications and trigeminal nerve stimulation were all tested at resting potential. Cell input resistance was estimated from the slope of the linear regression calculated on I-V curves (current-voltage relationship built by injecting current steps of different amplitudes). Repetitive firing properties were studied by injecting depolarizing square-pulses (500-ms duration). The peak amplitude of the slow afterhyperpolarization (AHP) was measured from the action potential threshold. The area and the maximal amplitude of PSPs were measured after filtering the spikes in the few instances where the latter occurred. The area was measured from the beginning of the response until the membrane potential returned to the resting level. The peak amplitude was the difference between the resting membrane potential and the maximum of the depolarization except if specified otherwise (early and late components in Fig. 5 ). Spikes were truncated in Figs. 4, 9, and 10 to reduce space.
Electrical stimulation of either the ipsi-or the contralateral trigeminal sensory root (single shocks of 2-ms duration at 0.1 Hz) was performed with a glass-coated tungsten microelectrode (4 -5 M⍀, either homemade or purchased from Micro Probe, Potomoc, MD) using a Grass S88 stimulator (Grass Instrument, Quincy, MA). The trigeminal-evoked PSPs were monitored several minutes before and . B1: superimposition of mean trigeminal-evoked excitatory postsynaptic potentials (EPSPs; averages of 3 traces each) in control (black) and after acetylcholine local application (gray) at RS neuron resting potential (V R ϭ Ϫ75 mV). B2: relative decrease in the EPSP peak amplitude (2 bars to the left) and area (2 bars to the right) after single acetylcholine ejection. Asterisk, P Ͻ 0.05; double asterisk, P Ͻ 0.01, data cumulated from 10 neurons. C: time course (relative to control value) of the EPSP area (square) and cell input resistance (circle) after a single acetylcholine ejection. Single experiment. The changes in input resistance were measured from the I-V curve slopes. Triple asterisk, P Ͻ 0.001; double asterisk, P Ͻ 0.01. All values of area were significantly smaller than control after ejection of acetylcholine (P Ͻ 0.001).
after drug applications (e.g., Fig. 1C ). All drugs were purchased from Sigma-Aldrich. Some of the drugs were applied locally: small droplets (0.5-10 nl) of acetylcholine (1 mM), pilocarpine (1 mM), muscarine (1 mM), atropine (1 mM), scopolamine (1 mM), N-methyl-D-aspartate (NMDA, 1 and 10 mM), or (Ϯ)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA, 1 mM), dissolved in freshly made Ringer, were pressure-applied locally (on the RS cells or the relay cell region) through a glass micropipette using a Picospritzer (General Valve, Fairfield, NJ; Fig. 1A ). The inactive dye Fast Green was added to the drug mixture to monitor the size of the application and the wash out of the drug. Control ejections of Ringer or Fast Green alone had no effects on the evoked PSPs. Atropine (10 M), strychnine (4 M), tetrodotoxin (TTX; 1 M), and phosphonovaleric acid (AP5; 200 M) were dissolved in the Ringer solution and bath applied. Between each drug application, a washout period was allowed for complete recovery, from 15 min to Ͼ1 h depending on the drug and the application technique used.
Data in the text and figures are given as means Ϯ SE The significance of changes in input resistance was assessed by the difference between the slopes (GraphPad Prism, GraphPad Software, San Diego, CA). The statistical significance for differences between means was determined with paired Student's t-test, using Origin software (OriginLab Corporation, Northampton, MA).
R E S U L T S

Muscarinic receptor-mediated modulation of the trigeminal inputs to RS neurons
Under control conditions, single stimulation shocks to the trigeminal sensory root on one side (Fig. 1A ) evoked large PSPs in RS neurons (see Viana Di Prisco et al. 1995) , and the amplitude of the responses remained constant from one stimulus to the other. After a local pressure-application of acetylcholine (1 mM) onto the recorded RS cell the PSPs were significantly depressed (Fig. 1B1) . The cumulated data from 10 RS neurons show that both the peak amplitude (86 Ϯ 5%; P Ͻ 0.05) and the area (50 Ϯ 6%; P Ͻ 0.01) of the trigeminalevoked PSPs were reduced (Fig. 1B2) . In most cases, the depression lasted for several tens of minutes (Fig. 1C) . On the other hand, there was no significant long-lasting change in the RS cell input resistance (105 Ϯ 2%; P Ͼ 0.05; n ϭ 8), except in two cells where a small but significant persistent increase occurred (e.g., Fig. 1C ). This suggests that the PSP depression produced by a local ejection of acetylcholine does not result from changes in RS neuron conductance.
We previously showed that acetylcholine produces large depolarizations in lamprey RS neurons resulting from the activation of nicotinic receptors (Le Ray et al. 2003) . However, nicotine ejection over RS cells never produced a long-lasting depression of the trigeminal-evoked PSPs (not illustrated), suggesting that muscarinic receptors may be involved. To test this, the muscarinic agonist pilocarpine (1 mM) was applied locally onto the recorded RS neurons ( Fig. 2 ; n ϭ 9) and, similarly to acetylcholine, it depressed the trigeminal-evoked PSPs (Fig. 2A1 ). Both the peak amplitude (75 Ϯ 16%; P Ͻ 0.01) and the area (76 Ϯ 26%; P Ͻ 0.01) of the synaptic responses were reduced (Fig. 2A2 ). The effects lasted for Ͼ1 h after washing out the drug (single experiment in Fig. 2B1 : P Ͻ 0.001; cumulated data in B2: P Ͻ 0.01). In contrast to the effects of acetylcholine, pilocarpine always increased (130 Ϯ 13%; P Ͻ 0.001; n ϭ 4) the input resistance of RS neurons (Fig. 2, B2 and C2), whereas there was no change in the membrane potential (Fig. 2C1) , suggesting a possible effect on leak channels.
We examined whether there was a tonic cholinergic modulation of trigeminal inputs onto RS cells. A bath application of the muscarinic antagonist atropine (10 M; not illustrated) increased both the peak amplitude (n ϭ 18; P Ͻ 0.05) and the area (n ϭ 18; P Ͻ 0.05) of trigeminal-evoked PSPs, but atropine did not affect the input resistance in the nine cells into which it was tested. Atropine (1 mM) was then pressure ejected locally onto the recorded RS cell while the trigeminal nerve was stimulated. It significantly enhanced the PSPs area in 4 of 15 RS cells (mean area of the 4 cells: 149 Ϯ 17% of the control; P Ͻ 0.05; Fig. 3A, 1 and 2 ). There were no significant FIG. 2. Effects of pilocarpine on the trigeminal-evoked PSPs in RS neurons. A1: superimposition of trigeminal-evoked (Trig. St) mean EPSPs (averages of 3 traces each) in an RS neuron in control (black) and after single local application of 1 mM pilocarpine (Pilo; gray) onto the recorded RS cell (V R ϭ Ϫ75 mV). A2: relative change of the EPSP peak amplitude and area after single pilocarpine ejection (gray). double asterisk, P Ͻ 0.01, data cumulated from 9 neurons. B1: time course (relative to control value) of the EPSP area in a single experiment after single pilocarpine ejection. B2: cumulated results (n ϭ 4) showing both the EPSP area (squares) and the input resistance (circles) after single pilocarpine ejection. The significance of differences between control and test mean values are given by the corresponding P values on the graph. C1: pilocarpine local pressure ejections failed to evoke responses from an RS neuron at resting potential (V R ϭ Ϫ76 mV). C2: current-voltage relationship before (empty circles) and after (filled circles) application of pilocarpine.
changes in the trigeminal-evoked PSPs in the other 11 cells. Neither the resting membrane potential nor the input resistance were changed by atropine (P Ͼ 0.05; Fig. 3B, 1-3 ). In preparations preincubated with atropine (n ϭ 2), a local application of acetylcholine failed to produce a depression of the trigeminal-evoked responses (not illustrated).
Because local applications of the muscarinic antagonist produced less reliable effects than those of bath applications, we investigated whether there was a muscarinic modulation of the trigeminal inputs at the level of the trigeminal relay cells. The interneurons relaying trigeminal inputs are located along the descending tract of the trigeminal nerve in the rhombencephalon (Northcutt 1979 ; G Viana Di Prisco, T Boutin, D Petropoulos, F Brocard, and R Dubuc, unpublished observations). Acetylcholine was pressure ejected over the region containing the relay cells (Fig. 4A1) . This resulted in a depression of the trigeminal-evoked PSPs (73 Ϯ 10%; P Ͻ 0.05; n ϭ 4; Fig. 4A, 2 and 3) . There was no effect in the early part of the PSPs (see detail in Fig. 4A2 ). Similarly, there was a depression of the trigeminal-evoked PSPs without changes of their early part of the response after pressure ejecting either pilocarpine (72 Ϯ 5%; P Ͻ 0.05; n ϭ 3; Fig. 4B ) or muscarine (61 Ϯ 11%; P Ͻ 0.05; n ϭ 3; not illustrated) in the same region, suggesting that muscarinic receptors are involved. In these experiments, FIG. 3. Trigeminal-evoked PSPs in RS cells before and after a local ejection of atropine onto RS cells. A1: superimposed trigeminal-evoked (Trig. St) mean EPSPs (averages of 3 traces each) recorded from an RS neuron (V R ϭ Ϫ75 mV) in control (black) and after local application of 1 mM atropine (gray) onto the recorded RS cell. A2: histogram of the mean area of the sensory-evoked EPSPs in control (black) and under atropine (gray). Asterisk, P Ͻ 0.05, data cumulated from 4 neurons. B: lack of effect of atropine on RS neuron input resistance. B1: sample recordings of voltage change in response to intracellular current injections under control (left) and after atropine (right). B2: current-voltage relationship under control (black) and after atropine (gray). B3: histogram illustrating the lack of effect of either a local ejection (n ϭ 4) or a bath application (n ϭ 9) of atropine (gray bar) on RS neurons input resistance. Asterisk, P Ͻ 0.05. the depression effect of the PSPs lasted for as long as when the agonists were ejected over RS cells. When atropine was applied over the region containing the trigeminal relay cells (Fig.  4C1) , the area of the PSPs was greatly enhanced (320 Ϯ 50%; P Ͻ 0.001; n ϭ 6; Fig. 4C3 ) to the point of generating multiple action potentials (see Fig. 4C2 ). However, the early part of the PSP remained unaffected (see detail Fig. 4C2) . A similar increase in the area of the trigeminal-evoked PSPs (320 Ϯ   FIG. 4 . Trigeminal-evoked PSPs in RS cells before and after a local ejection of acetylcholine, pilocarpine or atropine onto 2nd-order trigeminal neurons. A1: the size of the ejection is illustrated on a schematized brain stem. A2: superimposition of mean trigeminal-evoked EPSPs (averages of 3 traces each) in control (black) and after acetylcholine application (gray), V R ϭ Ϫ76 mV. The peak amplitude of early EPSP (arrowhead and detail) was not affected. A3: relative decrease of the EPSP area after acetylcholine ejection (gray, n ϭ 4 cells). B: pressure ejection of 1 mM pilocarpine over the trigeminal relay cells reduced the sensory-evoked EPSPs. B1: the size of the ejection is illustrated on a schematized brain stem. B2: superimposition of mean trigeminal-evoked EPSPs (averages of 3 traces each) in control (black) and after pilocarpine (Pilo) application (gray), V R ϭ Ϫ77 mV. The peak amplitude of early EPSP (arrowhead and detail) was not affected. B3: relative decrease of the EPSP area after pilocarpine ejection (gray, n ϭ 3 cells). C: pressure ejection of 1 mM atropine over the trigeminal relay cells enhanced the sensory-evoked EPSPs. C1: the size of the ejection is illustrated on a schematized brain stem. C2: superimposition of mean trigeminal-evoked EPSPs (averages of 3 traces each) in control (black) and after pilocarpine application (gray), V R ϭ Ϫ74 mV. The peak amplitude of early EPSP (arrowhead and detail) was not affected. Because under atropine the neuron usually developed a sustained depolarization that lasted several tens of seconds, the trace has been truncated for reason of space. C3: relative increased of the EPSP area after atropine ejection (gray, n ϭ 6 cells). Asterisk, P Ͻ 0.05; triple asterisk, P Ͻ 0.001. 29%; P Ͻ 0.01; n ϭ 4) also occurred when scopolamine was substituted for atropine in the ejection pipette (not illustrated). The effects of the muscarinic antagonists suggest that acetylcholine exerts a tonic depression of trigeminal inputs to RS cells through the activation of muscarinic receptors both at the relay site and at the level of RS cells in some cases.
Cellular target of the muscarinic modulation
Because trigeminal sensory inputs can consist of both glutamatergic EPSPs and glycinergic inhibitory PSPs (IPSPs) (Viana Di Prisco et al. 1995) , the muscarinic effects may have resulted from changes in inhibitory transmission. To test this, experiments (n ϭ 5) were performed in the presence of strychnine (4 M). Similarly to the results obtained in the absence of strychnine in the Ringer solution (see preceding text), atropine markedly increased the late part of the trigeminal-evoked EPSPs under strychnine (317 Ϯ 57%; P Ͻ 0.01; n ϭ 5; Fig. 5, A1 and B1 ). There was a small increase in the early part of the EPSPs although this was not statistically significant (149 Ϯ 20%; P Ͼ 0.05; n ϭ 5; Fig. 5, A2 and B2) , suggesting that strychnine could unmask an early excitation, sensitive to muscarinic modulation. We did not pursue this further, and additional experiments would be needed to test this hypothesis. Pilocarpine ejection was also tested on trigeminal-evoked EPSPs in the presence of strychnine. There was a significant decrease in the peak amplitude of the early EPSPs (69 Ϯ 5%; P Ͻ 0.01; n ϭ 3; not shown). These results suggest that there is a muscarinic modulation of the glutamatergic component of the trigeminal-evoked synaptic responses.
Atropine seemed to preferentially increase the late part of the trigeminal-evoked PSPs (Figs. 3 and 4C ). This would be consistent with a modulatory effect on the NMDA component of the synaptic potentials. We further examined if the muscarinic modulation was exerted differently on the NMDA and the AMPA/kainate glutamatergic components of the trigeminal inputs to RS cells. The effects of the muscarinic drugs were thus tested after blocking the NMDA receptors. After adding AP5 (200 M), the area of the PSPs was markedly reduced in all six cells tested (18.6 Ϯ 3.8% P Ͻ 0.01; Fig. 6, A and B) as previously described (Viana Di Prisco et al. 1995) . In the presence of AP5, atropine did not increase the area of the trigeminal-evoked PSPs (90 Ϯ 30%; P Ͼ 0.05; n ϭ 3; Fig. 6A , 1 and 2) nor did pilocarpine reduce it significantly (88.8 Ϯ 30%; P Ͼ 0.05; n ϭ 3; Fig. 6B, 1 and 2) . These results suggest that the NMDA receptor-mediated component of the trigeminal-evoked responses in RS cells is the main target of the muscarinic modulation.
To determine whether the muscarinic modulation of the NMDA component occurred at the level of the RS neuron, the effects of atropine (10 M, bath-applied) were tested on the depolarizing responses elicited by local ejections of two glutamatergic agonists onto RS neurons (Fig. 7, A and B) . The non-NMDA agonist AMPA (1 mM) evoked large depolarizations (Fig. 7A1 , black trace) that were not affected by atropine (gray trace). Neither the peak amplitude (n ϭ 12; Fig. 7A2 ; P Ͼ 0.05) nor the area (P Ͼ 0.05) of the depolarizing responses were modified; this confirmed that muscarinic modulation was not directed against non-NMDA responses. In contrast, the depolarizing responses evoked by a local ejection of 1 mM NMDA (Fig. 7B1 , black trace) were markedly enhanced in the presence of atropine (gray trace) such that both the peak amplitude (167 Ϯ 25%; P Ͻ 0.01) and the area (220 Ϯ 56%; P Ͻ 0.05) of the depolarizing responses were increased (n ϭ 24; Fig. 7B2 ). This suggests that at least a part of muscarinic modulation is exerted postsynaptically on the NMDA component of the excitation elicited in the target RS cells. It is noteworthy that the effects varied from one preparation to another. In 8 cases, atropine had little or no effect on the NMDA depolarization, whereas in the 16 other cases, there was a marked increase that reached a higher statistical significance (P Ͻ 0.001). These differences could result from variable levels of endogenous release of acetylcholine in different preparations.
Effects of muscarinic receptor activation on plateau potentials in RS cells
Strong cutaneous stimulation induces depolarizing plateaus in RS neurons that are involved in escape swimming in lampreys (Viana Di Prisco et al. 1997 . We have examined whether the depolarizing plateaus were subjected to a muscarinic modulation. In all of the RS cells tested (n ϭ 5), a bath application of atropine (10 M, 30 -60 min) enhanced the depolarization plateaus such that the area of the maximal responses was increased significantly on average to 544 Ϯ 84% with respect to the control in the five animals tested (P Ͻ 0.01; Fig. 8A, 1 and 2) . The threshold for inducing a depolarization plateau was also reduced to 50 Ϯ 25% of control value (P Ͻ 0.05; n ϭ 5). In four of five experiments, atropine increased the firing rate for maximal responses to 258 Ϯ 19% of control FIG. 5. Effect of atropine on trigeminal-evoked EPSPs, after blocking glycinergic synaptic transmission with strychnine. A1: superimposition of trigeminal-evoked EPSPs in Ringer containing strychnine (black) and in Ringer containing both strychnine and atropine (gray) at resting potential (V R ϭ Ϫ74 mV). A2: expanded time scale of A1 illustrating the changes occurring in the peak of the early component of the EPSP (arrowhead) measured 150 ms after the trigeminal stimulation. B1: histograms of the relative peak amplitude of the late part of the EPSP in strychnine (black) and in strychnine after adding atropine (gray). Double asterisk, P Ͻ 0.01, data cumulated from 5 neurons. B2: same as B1 but illustrating the peak amplitude of the early response (measured 150 ms after the trigeminal stimulation).
(P Ͻ 0.05; n ϭ 5; Fig. 8A3 ). Neither the input resistance nor the discharge properties measured with intracellular current injections were affected by atropine (Fig. 8B, 1 and 2 ; see also Fig. 3C ). Moreover, there was no significant change in the peak amplitude of the slow AHP (mean values in control: 10.7 Ϯ 1.7 vs. under atropine: 10.1 Ϯ 1.3 mV; P Ͼ 0.05; n ϭ 16; e.g., Fig.  8C ). It appears therefore that the increase in the firing rate results from an increase in the depolarization of the RS cell.
Intrinsic NMDA-evoked oscillations unmasked by atropine
Because depolarizing plateaus largely depend on NMDA receptor activation (Viana Di Prisco et al. 1997 and atropine enhances the occurrence of such depolarizing plateaus (see preceding text), we examined the impact of blocking muscarinic receptors on NMDA-induced plateau properties. Using a slightly leaking pipette (volume estimated at Ͻ1 l/min), NMDA (1 mM) was applied for several tens of seconds on intracellularly recorded RS neurons (n ϭ 5; Fig. 9 ). In control Ringer solution, NMDA generated a large-amplitude depolarization accompanied by sustained firing, which adapted after some 75-100 s (Fig. 9A1) . Then the membrane potential of the recorded cell remained depolarized throughout the NMDA application ( Fig. 9A1 ; see detail in A2). When 10 M atropine was added to the Ringer solution ( Fig. 9B1 ; see detail in B2), membrane potential oscillations appeared on top of the NMDA-evoked depolarization, and spiking occurred on top of each oscillation during the whole duration of the NMDAevoked oscillatory behavior (compare Fig. 9, A1 and B1) . Moreover, NMDA still induced oscillations after adding 1 M TTX to the atropine containing Ringer solution (Fig. 9C, 1 and  2) , whereas NMDA-induced oscillations did not occur in the presence of tetrodotoxin alone (Fig. 9D, 1 and 2) , suggesting that some RS neuron intrinsic properties were unmasked by the perfusion of the muscarinic antagonist. Interestingly, the presence of oscillations in RS neurons did not require long-lasting applications of NMDA as described in the preceding text. Similar oscillations under atropine could also be observed in response to a single focal ejection of NMDA (1-10 mM) onto the recorded RS cells (n ϭ 13; e.g., Fig. 10A ). Small oscillations of the membrane potential amplitude occurred when the RS neuron began to repolarize after a large NMDA-evoked depolarization (Fig. 10B, top) . There was then a slow increase in the amplitude of the oscillations, and action potentials were fired (Fig. 10B, bottom) . Because such oscillations were observed in the isolated rhombencephalon (n ϭ 6) in which the spinal cord was cut just below the PRRN, they could not result from ascending inputs conveyed by spinoreticular inputs from the locomotor networks (Dubuc and Grillner 1989; Vinay and Grillner 1993; Vinay et al. 1998) . In a few preparations (n ϭ 3) where the rhombencephalon was isolated from the rest of the CNS, oscillatory behavior in the form of repeated bursting could be observed in the absence of atropine, either in response to trigeminal sustained stimulation or "spontaneously" in the presence of strychnine. Interestingly in each of these cases, a single focal ejection of pilocarpine (2 mM) onto the recorded RS neuron was able to stop abruptly an ongoing burst and increase the time interval before the onset of the following bursts (ϳ70% increased delay; P Ͻ 0.05; n ϭ 5; not illustrated). The addition of 10 M atropine prevented the effect of the focal ejection of pilocarpine (n ϭ 4; not illustrated).
D I S C U S S I O N
Results from the present study show that there is a muscarinic modulation of the synaptic responses induced in RS cells by stimulation of trigeminal afferents. Muscarinic agonists depressed the trigeminal-evoked PSPs and muscarinic antagonists increased them. Atropine also potentiated the depolarizing responses induced by NMDA ejected on the recorded RS cell but not that induced by AMPA. Atropine also unmasked membrane potential oscillations in response to either a local application of NMDA or stimulation of trigeminal afferents.
Muscarinic modulation of the trigeminal glutamatergic sensory inputs
There is evidence, in different vertebrate nervous systems, for a muscarinic modulation of glutamatergic responses (e.g., in rats: Jiang and Dun 1986; in cats: Andre et al. 1995) . A muscarinic inhibition of glutamatergic responses was described in different regions of the CNS. In the spinal cord of neonate rats for example, acetylcholine induces an atropine-sensitive reduction of the sensory-evoked responses in motoneurons (Jiang and Dun 1986) . Similarly, the nonselective cholinergic agonist carbachol produces an atropine-sensitive depression of the glutamatergic transmission in neurons (Bellingham and Berger 1996; Marks and Roffwarg 1991; Metherate and Ashe 1995; Sim and Griffith 1996) . Likewise, muscarinic agonists such as oxotremorine (Lin and Phillis 1991) or muscarine or the acetylcholinesterase inhibitor physostigmine (Bellingham and Berger 1996) induce a comparable inhibition of glutamatergic inputs in various neuronal structures. The activation of muscarinic receptors by acetylcholine in pontine reticular giant neurons was proposed to be responsible for an inhibition of the startle reflexes induced by acoustic, visual, or tactile stimuli (see Fendt et al. 2001) . However, the mechanisms by which this inhibition is achieved are not understood.
We now show that the trigeminal glutamatergic inputs to RS cells of lampreys are subjected to a powerful muscarinic modulation. These inputs are carried by a disynaptic pathway from trigeminal afferents to RS cells, and thus the muscarinic modulation could be exerted at different locations along the pathway. In the present study, we provide evidence that the modulation occurs at the level of both the reticulospinal cell and of the trigeminal relay. A local ejection of muscarinic agonists onto RS neurons reduced the trigeminal-evoked PSPs significantly. Interestingly, a local ejection of atropine enhances the synaptic responses in some of the RS cells, suggesting that in the isolated brain stem preparation, there is tonic muscarinic depression of trigeminal inputs exerted at the level of the RS cell. The failure of atropine to potentiate the PSPs in some of these experiments when ejected over the recorded RS cell may result from either a variability of endogenous acetylcholine release among preparations or an absence of a significant activation of an NMDA component, the main substrate for the atropine-mediated modulation (see following text). Bath application of atropine on the other hand increased the trigeminal-evoked PSPs in all the cells tested. This prompted us to examine effects at the first synapse within this trigeminal pathway, that is, at the level of the trigeminal relay.
In all cases tested, atropine ejected over the relay cells enhanced markedly the synaptic responses to trigeminal stimulation, indicating that there was a strong muscarinic modula- FIG. 7. Effects of a muscarinic receptor antagonist on the local ejection of glutamatergic agonists onto the recorded RS cell. A1: superimposition of 1 mM AMPA-evoked depolarizations in control (black) and in the presence of 10 M atropine (gray) at resting potential (V R ϭ Ϫ75 mV). A2: histograms of the peak amplitude and area of the AMPA-evoked depolarization in control (black) and under atropine bath perfusion (gray). Data cumulated from 12 neurons. B1: superimposition of depolarizations evoked by 1 mM NMDA in control (black) and in the presence of atropine (gray) at resting potential (V R ϭ Ϫ75 mV). B2: histograms of the peak amplitude and area of the NMDA-evoked depolarization in control (black) and under atropine bath perfusion (gray). Asterisk, P Ͻ 0.05; double asterisk, P Ͻ 0.01, data cumulated from 24 neurons. tion also present at the level of the trigeminal relay in the brain stem. Local application of acetylcholine or selective muscarinic agonists over the trigeminal relay cells depressed the synaptic responses to trigeminal stimulation. Whether the modulation occurs presynaptically in primary afferent terminals or postsynaptically in the relay cells cannot be established yet.
Presynaptic inhibition by muscarinic receptors activation was previously shown between primary afferents and lamina II neurons of rat spinal cord (see Li et al. 2002) .
In most of the cases reported in the literature to date, the muscarinic modulation of glutamatergic synapses has been found to rely on presynaptic mechanisms (Bellingham and FIG. 8. Facilitation of sustained depolarizations by atropine. A1: responses elicited in RS neuron (V R ϭ Ϫ75 mV) to trigeminal nerve stimulation delivered at 2 intensities under control condition and in the presence of atropine (10 M). Note that in the control condition, a stronger stimulation induced a plateau potential sometimes accompanied by locomotor-related EPSPs (arrowheads) in a semi-intact preparation. A1: plot of relationship between the stimulus intensity and the response area in 1 RS cell before (squares) and during bath perfusion of atropine (gray triangles). A2: mean firing rate during plateau potential in control (black) and under atropine (gray), in 5 RS cells from 5 experiments. Double asterisk, P Ͻ 0.01; triple asterisk, P Ͻ 0.001. B1: lack of effect of atropine on spike frequency (V R ϭ Ϫ74 mV). B2: spiking was induced by injecting 500-ms current pulses of increasing intensity. C: lack of effect of atropine on the slow afterhyperpolarization (AHP) recorded at resting potential (V R ϭ Ϫ73 mV).
Berger 1996; Jiang and Dun 1986; Scanziani et al. 1995; Smolders et al. 1997) . We now provide evidence that the modulation occurs postsynaptically at least in part of the pathway. The response of RS cells to a local application of NMDA was potentiated by atropine perfusion. The increase was in the same range of that observed on the trigeminalevoked PSPs by atropine (area: ϩ120 Ϯ 56 vs. ϩ101 Ϯ 70%, and peak: ϩ67 Ϯ 25 vs. ϩ40 Ϯ 30%, respectively). Because the atropine-induced changes in the response to NMDA local application persist under TTX perfusion, it is likely that the effects occur postsynaptically at the level of the RS cell.
There are several lines of evidence, in the present study, indicating that the muscarinic modulation is predominantly exerted on the NMDA receptor-mediated component of the glutamatergic PSPs elicited by trigeminal stimulation: the depolarizing responses to direct application of NMDA onto the recorded RS cells were enhanced by atropine, whereas the responses to AMPA application were not; blocking NMDA receptors with AP5, abolished the effects of muscarinic agonists and antagonists on the trigeminal-evoked PSPs; muscarinic drug applications usually had little effect on the early part of the synaptic responses. Taken together these results suggest a predominant effect on NMDA receptor-mediated component of the excitation. Although it is clear that there is a muscarinic modulation that occurs at the trigeminal relay, whether there is an effect on the NMDA receptors of the relay cells is not established yet. To address this issue, it will be necessary to record from the relay cells to examine the effects of muscarinic drugs on the monosynaptic response to primary afferent stim- ulation and on their responses to direct application of glutamatergic agonists.
The mechanisms by which the activation of muscarinic receptors can modulate NMDA receptors remains to be determined in our preparation. Such mechanisms were examined in granule cell cultures (Courtney and Nicholls 1992) . It was shown that NMDA receptors in granule cells are inhibited by phospholipase-C-coupled muscarinic receptors. The AMPA/ kainate receptors are not. The authors identified the second messenger pathway involved revealing a muscarinic proteinkinase-C-mediated inhibition of NMDA receptors. Because we also show a muscarinic effect on NMDA receptors and no effect on AMPA/kainate receptors in the lamprey system, it is thus possible that similar cellular mechanisms are involved. Other studies have reported a postsynaptic modulation of a glutamatergic pathway by muscarinic receptors affecting either exclusively the AMPA/kainate subtype of glutamate receptors (Metherate and Ashe 1995) or both NMDA and non-NMDA receptor subtypes (Aramakis et al. 1997) .
Whether the muscarinic modulation is specific to the trigeminal inputs to RS cells in the lamprey system remains to be established. Preliminary experiments in our lab indicate that a muscarinic modulation is also exerted on vestibular inputs to RS cells. These results, although preliminary, suggest that the modulation could be present in other sensory pathways.
Muscarinic-induced changes of RS cell properties
Muscarinic agonists were shown to induce oscillatory properties in various species. In the lobster for example, their perfusion on the stomatogastric neuronal network transforms passive neurons into spontaneously bursting neurons, which display plateau properties that are responsible for the neuron oscillatory behavior (Bal et al. 1994) . Similarly in the rat, carbachol induces in the nonstellate neurons of the entorhinal cortex an atropine-sensitive bursting behavior that relies on an increase in intracellular calcium concentration (Klink and Alonso 1997a,b) and voltage-dependent plateau properties in subicular neurons (Kawasaki et al. 1999) . In lamprey RS neurons, intrinsic plateau potential and bursting properties are revealed by the bath perfusion of the muscarinic antagonist atropine. This suggests that, in this system, as in dorsolateral geniculate neurons of cats and guinea pigs (McCormick 1992) , the activation of muscarinic receptors would block endogenous bursting properties.
More than 20 years ago, NMDA-induced oscillations were described in interneurons and motoneurons of the lamprey spinal cord (Sigvardt and Grillner 1981; Sigvardt et al. 1985) . The oscillations were shown to be intrinsic to the spinal neurons as they persisted in the presence of TTX. We show that similar oscillations can occur in brain stem RS cells of lampreys but only after blocking muscarinic receptors. In the absence of muscarinic antagonists, only long-lasting depolarization plateaus are evoked by NMDA. The mechanism by which the oscillations occur in RS cells is unknown at this stage. If RS cells of lampreys were to display similar mechanisms than granules cells (Courtney and Nicholls 1992) it is possible that NMDA receptors would be tonically inhibited by muscarinic receptors and that adding the muscarinic antagonist atropine, removes this tonic inhibition. Oscillations could then be unmasked in the presence of NMDA. In spinal neurons, Ca 2ϩ is involved in both the initiation (through NMDA and voltage-dependent channels) and the termination (through the activation of K Ca channels) of oscillations (see Grillner et al. 2001) . The entry of calcium that would occur through the disinhibited NMDA receptors after blocking muscarinic receptors could contribute to the oscillations.
Functional considerations
The muscarinic antagonist atropine disclosed intrinsic oscillation properties underlying a bursting behavior in lamprey RS neurons in response to NMDA stimulation. To our knowledge, this is the first demonstration of such a property in RS neurons. The requirement of atropine for repetitive bursts to occur in response to a transient NMDA stimulation suggests that those oscillatory properties are tonically inhibited. A tonic muscarinic modulation was also reported in rat cortical neurons (Hess and Krawczyk 1996; Metherate and Ashe 1995) . The origin of this tonic modulation remains unknown in lamprey RS cells. Nevertheless, in higher vertebrates (for a review, see Fendt et al. 2001 ), cholinergic inputs projecting from both the pedunculopontine nucleus and the laterodorsal tegmentum to the reticular formation play a major role in the inhibition of startle responses. Because both of these brain stem regions contain cholinergic neurons and were recently described as part of the functionally defined MLR of lampreys (Le Ray et al. 2003; Pombal et al. 2001) , the MLR could thus be the origin of the muscarinic modulation of RS cells.
The MLR is involved in goal-directed locomotion (for a review, see Jordan 1998) , and a muscarinic control originating from that region could provide a fine tuning of the weight of sensory inputs to the RS system during complex motor behaviors. This would prevent inadequate reflex responses to perturb the MLR locomotor command. Such a muscarinic modulation of sensorimotor integration originating from the MLR exerts a prepulse inhibition of startle reflexes in pontine reticulospinal cells (see Fendt et al. 2001) . Furthermore, goal-directed locomotion requires a fine control from higher structures on RS command neurons that may be incompatible with a strong RS neuron activity such as a self-generated oscillatory behavior. Then, we can hypothesize that the MLR would silence such sensory-triggered intrinsic properties and this through the activation of muscarinic receptors on RS neurons (and probably also on relay interneurons). In contrast, sensory-evoked locomotor activity (such as an escape reaction) does not require higher brain centers (Cardin et al. 1999) . In this case, an oscillatory behavior generated at the RS level may, first, allow a sustained command onto spinal CPGs (because the oscillations permit a stronger firing than a single long duration plateau) and, second, reinforce the spinal-generated rhythm. This would presume the presence of mechanisms that regulate the cholinergic inputs from the MLR to RS cells in different behavioral contexts.
In lampreys, we recently demonstrated the role of nicotinic receptor-mediated cholinergic inputs to RS neurons in the initiation and the control of the MLR-evoked locomotion (Le Ray et al. 2003) . In the light of these results and the present ones, we propose that the MLR could send a dual cholinergic "command" to RS neurons. First an excitatory command, mediated by nicotinic receptors would activate precisely the RS system and trigger complex motor behaviors (such as exploratory behavior or prey attack). Second, an inhibitory command mediated by muscarinic receptors would be sent in parallel to reduce sensory transmission both at the first relay and at the level of RS cells. The cholinergic inputs would thus be responsible for a shift of RS neurons from a "reflex locomotor command" to "goal-directed locomotor command" state.
